• Explore /
  • Poster
  • / Serum IL-6 level to predict survival and treatment response in gastric and gastroesophageal junction cancer.

Serum IL-6 level to predict survival and treatment response in gastric and gastroesophageal junction cancer.

Abstract Poster

Authors

John Karalis

John D Karalis

University of Texas Southwestern Medical Center, Dallas, TX;

John D Karalis , Michelle R Ju , Lynn Y Yoon , Esther C Castro-Dubon , Suntrea Hammer , Matthew R. Porembka , Sam C. Wang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 444)

DOI

10.1200/JCO.2023.41.4_suppl.444

Abstract #

444

Poster Bd #

K10

Abstract Disclosures

Similar Posters

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Tumor regression grade and overall survival following gastrectomy with neoadjuvant therapy for gastric cancer.

Tumor regression grade and overall survival following gastrectomy with neoadjuvant therapy for gastric cancer.

First Author: Michelle A Savoldy

First Author: Rongsu Qi

First Author: Wei Guo

First Author: Rixci Ramirez